Thomas M. Moriarty - 01 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Apr 2022, 19:39:08 UTC
Prior SEC filing
17 Mar 2022
Next SEC filing
30 Jun 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas M. Moriarty

Key filing fact

Thomas M. Moriarty filed Form 4 for CVS HEALTH Corp (CVS) on 05 Apr 2022.

Key facts

  • This page summarizes Thomas M. Moriarty's Form 4 filing for CVS HEALTH Corp (CVS).
  • 3 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 05 Apr 2022, 19:39.

Change

  • Previous filing in this sequence was filed on 17 Mar 2022.
  • Current net transaction value: -$6,331,570.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS transaction

Common Stock

Tax liability

Transaction value
$10,700,781
Shares
-105,854
Change %
-13%
Price
$101.09
Shares after
730,897
Date
01 Apr 2022
Ownership
Direct
Footnotes
F1
CVS transaction

Common Stock

Tax liability

Transaction value
$359,476
Shares
-3,556
Change %
-0.48%
Price
$101.09
Shares after
735,349
Date
03 Apr 2022
Ownership
Direct
Footnotes
F2
CVS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
81,179
Date
01 Apr 2022
Ownership
By GRAT
CVS holding

Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
46,519
Date
01 Apr 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVS transaction Derivative

Stock Option

Award

Transaction value
$4,728,687
Shares
+46,777
Change %
Price
$101.09
Shares after
46,777
Date
01 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
46,777
Exercise price
$101.09
Footnotes
F3
CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
71,696
Date
01 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
71,696
Exercise price
$104.82
Footnotes
F4
CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
125,224
Date
01 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
125,224
Exercise price
$78.05
Footnotes
F5
CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
36,490
Date
01 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
36,490
Exercise price
$62.21
Footnotes
F6
CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
101,004
Date
01 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
101,004
Exercise price
$54.19
Footnotes
F7
CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
147,837
Date
01 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
147,837
Exercise price
$58.34
Footnotes
F8, F9
CVS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
155,495
Date
01 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
155,495
Exercise price
$74.30
Footnotes
F10
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 10 footnotes

Footnote F1

Surrender of shares in payment of withholding taxes due upon the vesting and settlement of the PSUs.

Footnote F2

Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022.

Footnote F3

Option becomes exercisable in four equal annual installments, commencing 4/1/2023.

Footnote F4

Option became exercisable in four equal annual installments, commencing 4/1/2017.

Footnote F5

Option became exercisable in four equal annual installments, commencing 4/3/2018.

Footnote F6

Option became exercisable in four equal annual installments, commencing 4/1/2019.

Footnote F7

Option became exercisable in four equal annual installments, commencing 4/1/2020.

Footnote F8

The number of shares subject to the option were calculated using a 30-day average price.

Footnote F9

Option became exercisable in four equal annual installments, commencing 4/1/2021.

Footnote F10

Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .